Evidence map›Paper›PMID 36309802›Full record

ArticleJournal of public health (Oxford, England)2023

Analysis of the UK Government's 10-Year Drugs Strategy-a resource for practitioners and policymakers.

Adam Holland, Alex Stevens, Magdalena Harris, Dan Lewer, Harry Sumnall, Daniel Stewart, Eilish Gilvarry, Alice Wiseman, Joshua Howkins, Jim McManus and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of public health (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Drug Addiction: Failure, Feast and Phoenix.International journal of environmental research and public health · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The New Zealand drug harms ranking study: A multi-criteria decision analysis.Journal of psychopharmacology (Oxford, England) · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 2 countries.

Adam HollandBristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.ORCID 0000-0002-3617-1966
Alex StevensSchool of Social Policy, Sociology and Social Research, University of Kent, Canterbury, CT2 7NZ.
Magdalena HarrisDepartment of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.
Dan LewerPublic Health Specialty Registrar, Department of Epidemiology and Public Health, University College London, London, WC1E 6BT, UK.ORCID 0000-0003-3698-7196
Harry SumnallPublic Health Institute, Liverpool John Moores University, Liverpool, L3 5UX, UK.
Daniel StewartBristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.ORCID 0000-0003-4368-2788
Eilish GilvarryPopulation Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, NE1 7RU, UK.
Alice WisemanAssociation of Directors of Public Health, London, EC4Y 0HA, UK.
Joshua HowkinsBristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
Jim McManusAssociation of Directors of Public Health, London, EC4Y 0HA, UK.
Gillian W ShorterSchool of Psychology, Queen's University Belfast, Belfast, BT7 1NN.
James NichollsFaculty of Health Sciences and Sport, University of Stirling, Stirling, FK9 4LA, UK.ORCID 0000-0003-4638-1972
Jenny ScottDepartment of Pharmacy & Pharmacology, University of Bath, Bath, BA2 7AY.
Kyla ThomasBristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
Leila ReidHepatitis C Trust, London, SE1 3YD, UK.
Edward DayInstitute of Mental Health, University of Birmingham, Birmingham, B15 2TT.
Jason HorsleyNational Institute for Health Research Evaluation Trials and Studies Coordinating Centre, University of Southampton, Southampton, SO17 1BJ, UK.
Fiona MeashamDepartment of Sociology, Social Policy and Criminology, University of Liverpool, Liverpool, L69 3BX.
Maggie RaeEpidemiological and Public Health Section, Royal Society of Medicine, London, W1G 0AE, UK.
Kevin FentonFaculty of Public Health, London, NW1 4LB, UK.
Matthew HickmanBristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
University of Bristol · GBInstitute of Directors · GBFaculty of Public Health · GBLiverpool John Moores University · GBNational Institute for Health Research · GBNewcastle University · GBPublic Health England · GBQueen's University Belfast · GBRoyal Society of Medicine · GBRoyal Society of Tropical Medicine and Hygiene · GBThe Hepatitis C Trust · GBUniversity of Bath · GBUniversity of Birmingham · GBUniversity of Kent · GBUniversity of Liverpool · GBUniversity of Stirling · GB

Funding

Medical Research Council MR/N00616X/1
6 · The paper itself

Abstract

In 2021, during a drug-related death crisis in the UK, the Government published its ten-year drugs strategy. This article, written in collaboration with the Faculty of Public Health and the Association of Directors of Public Health, assesses whether this Strategy is evidence-based and consistent with international calls to promote public health approaches to drugs, which put 'people, health and human rights at the centre'. Elements of the Strategy are welcome, including the promise of significant funding for drug treatment services, the effects of which will depend on how it is utilized by services and local commissioners and whether it is sustained. However, unevidenced and harmful measures to deter drug use by means of punishment continue to be promoted, which will have deleterious impacts on people who use drugs. An effective public health approach to drugs should tackle population-level risk factors, which may predispose to harmful patterns of drug use, including adverse childhood experiences and socioeconomic deprivation, and institute evidence-based measures to mitigate drug-related harm. This would likely be more effective, and just, than the continuation of policies rooted in enforcement. A more dramatic re-orientation of UK drug policy than that offered by the Strategy is overdue.

Indexed as

Public PolicySubstance-Related DisordersGovernmentHumansPublic HealthUnited KingdomaddictionGovernment and Lawpublic health

Identifiers

PMID36309802
PMCPMC10273368
OpenAlexW4307659023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.